Friday, October 8, 2010
The Riordan Clinic hosted 74 doctors and researchers from around the world to learn about the latest advancements in Vitamin C and cancer.
Medical professionals from six different countries and 23 states came to Wichita to attend the annual "Intravenous Vitamin C and Cancer Symposium" at the Riordan Clinic.
"It's exciting for us to be host of these many interested doctors who are asking very intelligent, articulate questions, highly scientific in terms of how the Vitamin C can improve their patients' outcomes," said Dr. Ron Hunninghake, Riordan Clinic chief medical officer.
In 1990, researchers at the Riordan Clinic started work on Vitamin C to learn about ways to help cancer patients have a better quality of life. Researchers found that certain levels of Vitamin C can kill tumor cells while keeping healthy cells healthy.
The Riordan Clinic primarily focuses on the use of high-dose intravenous Vitamin C to treat a wide variety of chronic conditions like arthritis and cancer.
"We developed the Riordan Protocol which is used by hundreds of physicians around the world and many of those physicians are here today to learn more about vitamin c and cancer," said Dr. Neil Riordan, Riordan Clinic board member.
Officials say that the Riordan Protocol for cancer is recognized in the integrative medicine community and is commonly used as an effective adjunct to conventional oncologic therapy.
To learn more about this therapy, click here. (http://riordanclinic.org/lifestyle/therapies/high-dose-iv-vitamin-c.shtml)